Graduate studies at Western
Journal of Medical Ethics 25 (4):309-314 (1999)
|Abstract||OBJECTIVE: To report and analyse the pattern of end-of-life decision making for terminal Chinese cancer patients. DESIGN: Retrospective descriptive study. SETTING: A cancer clinical trials unit in a large teaching hospital. PATIENTS: From April 1992 to August 1997, 177 consecutive deaths of cancer clinical trial patients were studied. MAIN MEASUREMENT: Basic demographic data, patient status at the time of signing a DNR consent, or at the moment of returning home to die are documented, and circumstances surrounding these events evaluated. RESULTS: DNR orders were written for 64.4% of patients. Patients in pain (odds ratio 0.45, 95% CI 0.22-0.89), especially if requiring opioid analgesia (odds ratio 0.40, 95% CI 0.21-0.77), were factors associated with a higher probability of such an order. Thirty-five patients were taken home to die, a more likely occurrence if the patient was over 75 years (odds ratio 0.12, 95% CI 0.04-0.34), had children (odds ratio 0.14, 95% CI 0.02-0.79), had Taiwanese as a first language (odds ratio 6.74, 95% CI 3.04-14.93), or was unable to intake orally (odds ratio 2.73, 95% CI 1.26-5.92). CPR was performed in 30 patients, none survived to discharge. CONCLUSIONS: DNR orders are instituted in a large proportion of dying Chinese cancer patients in a cancer centre, however, the order is seldom signed by the patient personally. This study also illustrates that as many as 20% of dying patients are taken home to die, in accordance with local custom|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
T. -H. Jaing, P. -K. Tsay, E. -C. Fang, S. -H. Yang, S. -H. Chen, C. -P. Yang & I. -J. Hung (2007). "Do-Not-Resuscitate" Orders in Patients with Cancer at a Children's Hospital in Taiwan. Journal of Medical Ethics 33 (4):194-196.
Myriam Skrutkowska & Charles Weijer, Do Patients with Breast Cancer Participating in Clinical Trials Receive Better Nursing Care?
Charles Weijer, Benjamin Freedman, Abraham Fuks, James Robbins, Stanley Shapiro & Myriam Skrutkowska, What Difference Does It Make to Be Treated in a Clinical Trial? A Pilot Study.
Frederic Bretzner, Frederic Gilbert, Françoise Baylis & Robert M. Brownstone (2011). Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury. Cell Stem Cell 8 (5):468-475.
Daniel Wei L. Wang & Octavio Luiz Motta Ferraz (2012). Pharmaceutical Companies Vs. The State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil? Journal of Law, Medicine and Ethics 40 (2):188-196.
Susan Gilbert (2010). Personalized Cancer Care in an Age of Anxiety. Hastings Center Report 40 (5):18-21.
Jerry Menikoff (2006). What the Doctor Didn't Say: The Hidden Truth About Medical Research. Oxford University Press.
Ana Smith Iltis (2005). Third-Party Payers and the Costs of Biomedical Research. Kennedy Institute of Ethics Journal 15 (2):135-160.
Fred Gifford (2000). Freedman's 'Clinical Equipoise' and Sliding-Scale All-Dimensions-Considered Equipoise'. Journal of Medicine and Philosophy 25 (4):399 – 426.
Winston Chiong (2006). The Real Problem with Equipoise. American Journal of Bioethics 6 (4):37 – 47.
Jacek Spławiński & Jerzy Kuźniar (2004). Clinical Trials: Active Control Vs Placebo — What is Ethical? Science and Engineering Ethics 10 (1):73-79.
E. Mok (2001). Empowerment of Cancer Patients: From a Chinese Perspective. Nursing Ethics 8 (1):69-76.
Rebecca Dresser (2011). Bioethics and Cancer: When the Professional Becomes Personal. Hastings Center Report 41 (6):14-18.
Sorry, there are not enough data points to plot this chart.
Added to index2010-09-13
Recent downloads (6 months)0
How can I increase my downloads?